-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
MSD biomarker assays are enabling development of immunotherapies and enhancing pre-clinical and clin
...
-
Translational Immunology
Critical reagent risk mitigation strategies Potential improvements in efficiency for preclinical and
...
-
Clinical Development
FDA on going design requirements Applications to C> Global impact Cohort management
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
Afternoon Refreshments
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
Evening Drinks Reception
-
Immune Regulation
Immune homeostasis through strong interplay between innate and adaptive system Dysregulation of the
...
-
Clinical Development
When is project Optimus a concussive approach? How to assess and determine contribution of component
...
-
Translational Immunology
Does IL-10’s in vivo anti-inflammatory function translate to humans? Does IL-10’s in vivo adaptive s
...
-
Immunogenicity
Is it possible to down-regulate immune responses to prevent production of anti-drug antibodies? Can
...
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
1-2-1 Meetings / Networking Break
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
1-2-1 Meetings / Networking Break
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
Networking Lunch
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
Morning Refreshments
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
1-2-1 Meetings / Networking Break
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
1-2-1 Meetings / Networking Break
-
Immune Regulation
Risks of side effects caused by dysregulated immune system in drug development Potential risks of im
...
-
Clinical Development
How will targeting the tumor microenvironment open new avenues for drug development? What does the s
...
-
Translational Immunology
What is the role of multi-omics in identifying biomarkers for disease diagnosis, prognosis, and trea
...
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
Drug development in immunotherapies is rapidly evolving with multiple new guidances from the FDA and
...
-
-
Immunogenicity
-
Translational Immunology
-
Clinical Development
-
Immune Regulation
Registration
)
MSD biomarker assays are enabling development of immunotherapies and enhancing pre-clinical and clin ...)
FDA on going design requirements Applications to C> Global impact Cohort management
)
)
)
)
)
)
)